Industries > Pharma > Global Clinical Nutrition Market Forecast 2019-2029

Global Clinical Nutrition Market Forecast 2019-2029

Infant Nutrition, Enteral Nutrition, Parenteral Nutrition

PAGES: 144
PRODUCT CODE: PHA0388

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0388 Categories: , Tags: ,

The global clinical nutrition market is estimated at $41bn in 2016 and is expected to grow at a CAGR of 5.3% from 2017-2027. The infant nutrition segment held the largest market share, with $24.1 billion in value in 2016 and is expected to grow at a CAGR of 4.9% for the period 2017-2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 144-page report you will receive 150 charts – all unavailable elsewhere.

The 144-page report provides clear detailed insight into the global clinical nutrition market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Clinical Nutrition Market forecasts from 2019-2029

This report also shows forecast revenue to 2029 for the leading segments and sub segments of the clinical nutrition market:

Infant Nutrition:
– Milk-based
– Soy-based
– Organic
– Probiotic / prebiotic
– Others

Enteral Nutrition
– Standard
– Enteral Nutrition for Chronic Illnesses

Parenteral Nutrition

Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
– North America: the US and Rest of North America
– Europe: Germany, France, the UK and Rest of Europe
– Asia-Pacific: China, Japan, India and Rest of Asia-Pacific
– Rest of the World (RoW): Middle East and Rest of RoW

Global Clinical Nutrition Market Forecast 2017-2027

Each regional market is further segmented into the leading segments and sub segments of the clinical nutrition market. Whereas, each national market is further segmented into the leading segments of the clinical nutrition market.

• This report discusses the leading companies that hold the majority of market shares in the clinical nutrition market:
– Baxter International
– Abbott Laboratories
– B. Braun Melsungen AG
– Nestle S.A.
– Groupe Danone
– Mead Johnson
– Fresenius Kabi
– Hospira
– Perrigo

• This report also discusses Porter’s Five Forces Analysis. These forces analyze the clinical nutrition market from five different perspectives such as competitive rivalry within the industry; threat of new entrants; bargaining power of suppliers; bargaining power of buyers; and threat of substitute products.

Visiongain’s study is intended for anyone requiring commercial analyses for the clinical nutrition market. You find data, trends and predictions.

Buy our report today Global Clinical Nutrition Market Forecast 2019-2029: Infant Nutrition, Enteral Nutrition, Parenteral Nutrition.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029

      Latest Pharma news

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ

      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ